In contrast, no evidence of association was obtained between HMMR variation and breast cancer risk in BRCA2 mutation carriers; specifically, rs299290 per-allele HR = 0.98, 95% CI 0.92–1.05, p = 0.57. This evidence concerns the gene BRCA2 and breast carcinoma.